Peng Kong
- Molecular Biology top 10%
- Immunology top 5%
- Cancer Research top 5%
- Oncology
- Surgery
- Topics
- Cancer-related molecular mechanisms research (10 papers)Circular RNAs in diseases (10 papers)MicroRNA in disease regulation (7 papers)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Peng Kong
46 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 803
- Immunology 567
- Cancer Research 486
- Oncology 165
- Surgery 153
Countries citing papers authored by Peng Kong
This map shows the geographic impact of Peng Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Kong more than expected).
Fields of papers citing papers by Peng Kong
This network shows the impact of papers produced by Peng Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Kong. The network helps show where Peng Kong may publish in the future.
Co-authorship network of co-authors of Peng Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Peng Kong. A scholar is included among the top collaborators of Peng Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Kong. Peng Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 8 | |
| 7 | 35 | |
| 8 | 1 | |
| 9 | Inflammation and atherosclerosis: signaling pathways and therapeutic interventionbreakdown → | 640 |
| 10 | 24 | |
| 11 | 15 | |
| 12 | 6 | |
| 13 | 5 | |
| 14 | 15 | |
| 15 | 17 | |
| 16 | 0 | |
| 17 | 12 | |
| 18 | 31 | |
| 19 | 54 | |
| 20 | 52 |
About Peng Kong
Peng Kong is a scholar working on Cancer Research, Immunology and Oncology, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (10 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (486 citations), Immunology (567 citations) and Molecular Biology (803 citations). Peng Kong has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Mei Han, Dandan Zhang, Ziyang Cui, Zhiyong Wang, Cui-Luan Yao, Mei Han, Peifeng Ji, Binghui Li, Yabin Liu and Wenbin Zhou. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.